Work

Figure S4 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis

Year: 2025

Type: review

Abstract: Figure S4 shows the Evaluation of the utility of regarding the 95% CI RR for late-stage incidence as a “forecast” of the final trial result for cancer-specific mortality, only including 15 trial arm comparisons with the late-stage outcome RR reported prior to the primary analysis for mortality but after the screening period had ended.

DOI: 10.1158/1055-9965.30271520

Authors: Matejka Rebolj, Adam R. Brentnall, Julia Geppert, Nefeli Kouppa, Bethany Shinkins, Karoline Freeman, Chris Stinton, Matthew J. Randell, Samantha Johnson, Robert A. Smith, Peter Sasieni, Sam M. Janes, Ruth Etzioni, Stephen W. Duffy, Sian Taylor-Phillips

Language: English

Topic: Global Cancer Incidence and Screening

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4414796012

FWCI:

Cites:

Cited by:

Related to: